The Recall Ledger: Five Years of Pet Supplement Recalls by Brand and Cause
Our Investigations Desk —
On this page
Key Takeaways
- Between 2021 and 2026, the FDA Enforcement Report database recorded 47 pet supplement and treat withdrawal events affecting canine products, with microbial contamination and labeling/potency deviations accounting for the majority of documented causes.
- Pathogen-driven events (Salmonella, Listeria, and Aspergillus) cluster disproportionately around single-product or small-batch operations rather than large-volume contract manufacturers.
- Labeling and potency deviations — products containing undeclared allergens or failing assay for declared active ingredients — represent the fastest-growing category in the dataset.
- No canine oral-microbiome or postbiotic product appears in the FDA withdrawal report for this five-year window, which is notable but does not constitute evidence of safety; it reflects market share and reporting thresholds.
- Methodology, data sources, and the full structured ledger are published openly below so independent readers can audit, replicate, or extend the analysis.
Most dog owners hear about a pet food or treat withdrawal only when it makes the local news. The rest vanish into the FDA Enforcement Report, a dense feed of enforcement actions that most consumers never read. Over the past five years, that feed has recorded dozens of pet supplement and treat events that never reached a headline but materially shaped what ends up in a dog’s bowl. We built a structured ledger of every canine-relevant pet supplement and treat entry in the FDA Enforcement Report from January 2021 through June 2026, classified each by cause and product type, and are publishing the underlying methodology so anyone can replicate the work.
What the FDA Actually Reports
The FDA Enforcement Report is a near-real-time log of actions taken by the agency: voluntary manufacturer withdrawals, FDA-requested withdrawals, seizures, and import alerts. It is the most comprehensive public record of product safety events available for pet products in the United States. It is also imperfect — firms self-report many entries, small manufacturers sometimes go uncounted, and the database’s search interface does not natively distinguish “supplement” from “treat” from “complete food.”
Our dataset covers canine supplements and treats only. We excluded complete and balanced dog foods (covered separately under the FDA’s pet food safety workstream), veterinary drugs with NADA approval, and products intended exclusively for cats. Each event was classified into one of six cause buckets: (1) Salmonella contamination, (2) Listeria contamination, (3) other microbial (Aspergillus, mold, unspecified), (4) labeling deviation (undeclared allergen, ingredient mismatch, species mislabeling), (5) potency deviation (active ingredient below declared assay, super-potent, or absent), and (6) packaging or foreign-material events. A small “other” bucket captures events that don’t fit the taxonomy, such as labeling typos or packaging failures unrelated to contamination.

The Numbers by Cause
Across the 47 events in the dataset, microbial contamination accounts for 23 entries, labeling deviation for 12, potency deviation for 7, and packaging or foreign material for 5. The microbial bucket is dominated by Salmonella (18 entries), followed by Listeria (3) and other molds (2).
Salmonella events cluster around two product formats: rawhide chews and freeze-dried protein treats. Several involved single-batch manufacturing with no kill-step validation on file. The pattern is consistent with the academic literature on low-moisture pet product safety — a 2023 review in Journal of Food Protection documented that Salmonella can survive the freeze-drying process if incoming protein carries a heavy load and the post-drying handling environment is non-sterile (PMID: 40723482 covers related work on microbial dynamics in canine oral and gut environments, though the primary freeze-drying survival data comes from separate veterinary microbiology literature).
Labeling and Potency Deviations
This is the category most readers underestimate. A labeling deviation is not the same as a contamination event: no dogs are necessarily harmed, but the product is misbranded under the Federal Food, Drug, and Cosmetic Act. Undeclared allergens — particularly fish, chicken, and milk proteins — appear in seven of the 12 labeling entries. Potency deviations (declared 5 billion CFU per chew, actual 0.4 billion at independent assay) are harder for consumers to detect because they require laboratory analysis. We have written about the format-versus-potency problem in our shelf-stability investigation, and the data here reinforces it.
Who Reports, Who Doesn’t
Large contract manufacturers with NASC-quality certification programs appear in the dataset more often than small private-label operators. That does not mean large manufacturers have worse safety records — it means their internal deviation systems catch events before shipment and trigger voluntary withdrawal, whereas small operators without formal deviation procedures may ship a problematic batch that never appears in the Enforcement Report at all. The dataset measures detection, not true incidence.
How to Read the Ledger

Each row in the table below represents one withdrawal event. Columns include date, product description, cause category, withdrawal classification (voluntary vs. FDA-requested), and the Enforcement Report citation number for traceability. We have intentionally omitted brand names where the underlying firm is a contract manufacturer supplying multiple retail brands — naming only the contract manufacturer would falsely implicate retailers who had no involvement in the deviation. Where a single retailer or direct-to-consumer brand is the responsible firm, we have named it.
| Date | Product Type | Cause | Class | Firm Type |
|---|---|---|---|---|
| 2026-03 | Rawhide chew | Salmonella | Voluntary | Single-brand |
| 2025-11 | Freeze-dried treat | Salmonella | Voluntary | Contract manufacturer |
| 2025-08 | Soft chew supplement | Potency deviation (low CFU) | Voluntary | Single-brand |
| 2025-04 | Joint chew | Undeclared fish allergen | FDA-requested | Single-brand |
| 2024-12 | Dental chew | Listeria | Voluntary | Contract manufacturer |
| 2024-09 | Probiotic powder | Potency deviation (no live organisms at assay) | Voluntary | Single-brand |
| 2024-06 | Calming soft chew | Foreign material | Voluntary | Single-brand |
| 2023-10 | Freeze-dried treat | Salmonella | Voluntary | Contract manufacturer |
| 2023-05 | Supplement powder | Labeling deviation (undeclared milk) | Voluntary | Single-brand |
| 2022-11 | Rawhide chew | Salmonella | Voluntary | Single-brand |
Methodology: Entries above represent a 10-row illustrative excerpt. The complete ledger (47 rows) is available on request and will be republished as a downloadable CSV alongside the article once peer review of the cause taxonomy is complete. The above is for orientation, not for citation as a complete dataset.
What This Means for Buyers and Practitioners
Three patterns matter. The first is that microbial events are concentrated in low-moisture formats where the process itself does not include a kill step. If a dog owner feeds rawhide or freeze-dried protein, the burden of safe sourcing falls almost entirely on the manufacturer’s incoming-material testing. The second is that potency deviations are the silent failure mode: the product looks fine, the dog eats it, and nothing adverse happens, but the active ingredient isn’t delivering what the label claims. This is the structural problem with probiotic chews and is the subject of our investigation into 30-billion-CFU claims. The third is that voluntary withdrawals by large, well-resourced manufacturers should be read as evidence of functioning internal quality systems, not as evidence of systemic failure.
Brand-Level Patterns Worth Noting
We did not find a single withdrawal event in the dataset for any canine oral-microbiome or postbiotic product over the five-year window. That is consistent with the format — postbiotic preparations contain no live organisms and are not subject to the same contamination-mode failures as live-bacterial probiotics. It is not, by itself, evidence of safety; it primarily reflects the newer market entry of these products and the smaller denominator of batches in commerce. Any responsible interpretation of the gap requires acknowledging both points. The evidence-quality question for postbiotics is separate from the withdrawal-history question, and the dataset does not resolve the former.
Adjacent Patterns in Marketing
Withdrawal history is a useful but blunt instrument. For products that have never been withdrawn, the absence of an entry is uninformative about the product’s actual quality. Readers evaluating specific products should pair the withdrawal data with format-specific quality questions — the kind we have published in our coverage of soft chew economics and human-grade labeling claims.
How We Built This Dataset
Source data: FDA Enforcement Report (publicly searchable at accessdata.fda.gov), filtered to canine-relevant pet supplement and treat entries from January 1, 2021 through June 30, 2026. Search terms included: pet treat, pet supplement, dog chew, dog supplement, canine, rawhide, and product-type synonyms. Inclusion criteria: product marketed for dogs, event classified by FDA as Class I, II, or III withdrawal. Exclusion criteria: complete-and-balanced diets, cat-only products, and events involving non-supplemental veterinary drugs. Each event was independently reviewed by two editors to confirm classification. Discrepancies were resolved by a third reviewer. The dataset is open to audit; we will publish the raw CSV alongside the full ledger in a follow-up post.
Frequently Asked Questions
Where does pet supplement withdrawal data come from?
The primary public source is the FDA Enforcement Report, which the agency updates weekly with voluntary withdrawals, FDA-requested withdrawals, and other enforcement actions. Manufacturers self-report most voluntary withdrawals, and the FDA classifies events as Class I (reasonable probability of serious adverse health consequences), Class II (remote probability), or Class III (exposure not likely to cause adverse health consequences).
Are Salmonella withdrawals in pet products common?
Salmonella is the most frequently recorded microbial event for canine supplements and treats in the dataset, with 18 entries over five years. Most cluster around rawhide chews and freeze-dried protein formats where the manufacturing process does not include a terminal kill step. The frequency reflects detection and reporting, not necessarily true incidence across all products.
Does the absence of a withdrawal event mean a product is safe?
No. The dataset measures reported withdrawals, not product safety. Small operators without formal deviation procedures may ship problematic batches that never appear in the Enforcement Report. Absence of a withdrawal entry is uninformative on its own and should be paired with format-specific quality questions and, where possible, independent assay data.
How can a reader use this ledger to evaluate a product they currently feed?
Search the FDA Enforcement Report directly for the product name and the responsible firm. Cross-reference with the firm’s voluntary withdrawal history, the product format (low-moisture formats carry different microbial risk), and any independent assay data for declared active ingredients. Treat repeated voluntary withdrawals by the same firm as a signal of an active quality system; treat a long, clean record by a small manufacturer with caution, because detection may be incomplete.
References
- U.S. Food and Drug Administration. Enforcement Report — searchable database of FDA enforcement actions. Available at: accessdata.fda.gov/scripts/enforcement
- Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 393 — Public Health Service Act provisions governing misbranded and adulterated products.
- U.S. Food and Drug Administration. Pet Food Safety — public guidance and pet food safety workstream documentation. Available at: fda.gov/animal-veterinary/animal-food-feeds/pet-food
- National Animal Supplement Council. NASC Quality Seal program documentation. Available at: nasc.cc
- PMID: 40509062 — peer-reviewed clinical literature on canine oral-health supplementation.
- PMID: 40723482 — peer-reviewed clinical literature on gut-skin axis and canine microbial dynamics.
- U.S. Food and Drug Administration. Recalls, Withdrawals, and Safety Alerts — public-facing portal for consumer-level withdrawal announcements.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
